Scientific Program

Conference Series LLC Ltd invites all the participants across the globe to attend 16 th International Conference on Surgery and Anesthesia Vancouver, Canada.

Day 1 :

Anesthesia-2022 International Conference Keynote Speaker Tom Morrison photo

Dr Morrison completed his Doctor of Medicine at the University of New South Wales in 2017. He is currently a neurosurgery registrar at Royal Prince Alfred Hospital in Sydney. In 2019 he was awarded NSW Junior Medical Officer of the Year.


Carotid artery pseudoaneurysm is a rare complication of transsphenoidal surgery, usually diagnosed within 90 days post procedure. Pseudoaneurysm rupture may present with severe epistaxis or carotid cavernous fistula (CCF) with significant morbidity and mortality. We present a case of epistaxis from pseudoaneurysm rupture over a decade after transsphenoidal surgery. The pseudoaneurysm was treated with staged balloon-assisted coiling, endonasal mucosal flap repair and interval flow-diverting stent insertion. This case illustrates that pseudoaneurysms develop and rupture regardless of postoperative time course after transsphenoidal surgery, and the treatment complexities involving combined endovascular and endonasal techniques.

Anesthesia-2022 International Conference Keynote Speaker Tugba Han Öner photo


Background: This study evaluated the relationship between preoperative neutrophil / lymphocyte ratio - platelet / lymphocyte ratio, clinicopathological, radiological factors, and axillary lymph node metastasis in stage I-III breast cancer to determine if axillary surgery can be safely omitted in selected patients.

Methods: The study included 158 Stage I-III breast cancer patients operated on at Baskent University Zubeyde Hanim Research Center between 2011 and 2018. The incidence of axillary lymph node metastasis was correlated with clinical, radiological, pathological, and laboratory (neutrophil count to lymphocyte count, platelet count to lymphocyte count) findings by univariate and multivariate analyses. Sensitivity and specificity calculations, positive predictive value, negative predictive value, positive and negative Likelihood Ratio (accuracy ratio), and exact accuracy were calculated for neutrophil/lymphocyte ratio cut-off values of 3.5 and 1.

Results: Neutrophil and platelet values were significantly higher in patients with lymph node metastasis. Neutrophil / lymphocyte ratio - platelet / lymphocyte ratio values were higher in patients with axillary lymph node metastasis, but this was not statistically significant. Axillary lymph node metastasis was not associated with age, lymphocyte, monocyte count, estrogen receptor, progesterone receptor, or c-erb B2 status. The incidence of axillary lymph node metastasis was statistically significantly higher in the presence of lymphovascular invasion. Sensitivity, specificity, positive predictive value, and negative predictive value were 93.85%, 16.67%, 44.9%, and 78.9% respectively for axillary lymph node metastasis while the neutrophil / lymphocyte ratio was ≥ 3.5. Specificity, sensitivity, positive predictive value, and negative predictive value were 97.78%, 9.23%, 75.0%, and 59.9% respectively for axillary lymph node metastasis while the neutrophil / lymphocyte ratio < 1.

Conclusions: For axillary lymph node metastasis, neutrophil, platelet counts, lymphovascular invasion status, radiological and pathological mass size, and presence of radiological axillary lymphadenopathy are the statistically significant independent variables. They provide information that can help surgeons decide on the treatment of breast cancer patients with certain neutrophil / lymphocyte ratio values (neutrophil / lymphocyte ratio < 1 and neutrophil / lymphocyte ratio ≥ 3.5).

Anesthesia-2022 International Conference Keynote Speaker H. Damirji photo

Dr Hana Damirji is an anaesthetics and intensive care trainee currently working at the Lister Hospital in Stevenage, UK. She completed her medical training in London, graduating from University College London in 2015 with distinction and also obtaining first class honors in Neuroscience iBSc. Previous publications include the initiation of a debriefing session for intensive care trainees, which NHS Improvement listed as one of the top 10 quality improvement measures of 2017. ​


Introduction: Since the national shortage of diamorphine began in late 2018, preservative-free morphine has been used as an alternative adjunct to local anaesthetics in intrathecal blockade in obstetrics. An initial departmental audit following this enforced change to morphine established a statistically significant increased risk of PONV and reduced patient satisfaction compared with previous diamorphine use. A statistically significant link between intrathecal morphine and reduced post-operative oramorph use was also found. These finding correlate with the different pharmacodynamic profiles of the two drugs. The aim of our re-audit was to evaluate the way in which morphine use changed over time, following our initial audit feedback and with increased familiarity, within our department.


Methods: All obstetric anaesthetic interventions at the Lister Hospital are routinely recorded electronically on the Xentec Epidural Audit System. Data is collected on completion of the procedure and during a post-procedure follow-up 1-3 days later.

Data points collected immediately post-procedure include choice of intrathecal opiod and adequacy of block intra-operatively. On follow-up data collected includes overall patient satisfaction, side-effects experienced (including severe PONV and pruritis) and post-operative oramorph requirement. Parturients undergoing intrathecal blockade with morphine (n=104) between 13/07/18 and 20/09/18 had been previously audited. This data set represented the initial use of intrathecal morphine as an alternative to diamorphine: Morphine 1. Upon completion, these audit findings were presented at a local departmental meeting where results were displayed with no protocolised changes suggested or enforced. Post-presentation and following a period of time, a second data set was taken analysing parturients undergoing intrathecal blockade with morphine between 05/09/19 and 01/03/20 (n=374): Morphine 2. Data from these two audit sets were then analysed for comparison.


Results: Statistical analysis was carried out using Chi-Squared tests and results deemed significant if p < 0.05. There was a statistically significant increase in overall patient satisfaction and regional adequacy in the Morphine 2 group versus Morphine 1, with p values of 0.0006 and 0.0051 respectively.  However, no statistically significant change was seen in incidence of severe PONV and pruritis or in post-operative oramorph requirements between  the two groups.


Conclusions: The results above show an overall improvement in patient satisfaction and intra-operative adequacy of intrathecal blockade with morphine use over time. This most likely represents an increased familiarity with intrathecal morphine use as well as changes in practice following presentation of the initial audit results. Practitioners have reported modifications in terms of morphine dosing and/or addition of a second intrathecal adjust, fentanyl. The later agent has the benefit of augmenting the regional blockade more rapidly than morphine whilst not significantly contributing to side-effects experienced. Furthermore, this may account for the lack of change in post-operative oramorph requirement despite a statistically significant improvement in intrathecal block adequacy. Future audits should focus on comparing specific doses of intrathecal morphine and use of a second opiod adjunct.